Macular degeneration: open trials in Japan

• NCT07064759

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  Trial Treatment · Phase 3 · 4D Molecular Therapeutics

  Toho University Medical Center Sakura Hospital, Chiba · Hayashi Eye Hospital, Fukuoka · Kyushu University Hospital, Fukuoka · Social Medical Corporation Foundation Chiyuukai Fukuoka Wajiro Hospital, Fukuoka · Fukushima Medical University Hospital, Fukushima · University of the Ryukyus Hospital, Ginowan · Hyogo Prefectural Amagasaki General Medical Center, Hyōgo · Kozawa Eye Hospital and Diabetes Center, Mito · University of Miyazaki Hospital, Miyazaki · Nagoya University Hospital, Nagoya · National Hospital Organization Tokyo Medical Center, Tokyo

  Registry updated 2026-10-19

• NCT07614776

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  Trial Treatment · Phase 3 · Amgen

  Tokyo Medical Center - Ophthalmology, Meguro-ku · SUGITA EYE HOSPITAL - Ophthalmology, Nagoya · Nihon University Hospital - Ophthalmology, Tokyo · Tokushima University Hospital - Ophthalmology, Ube

  Registry updated 2026-10-14

• NCT07441642

  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Bunkyo Ku · Chiyoda-ku · Kobe

  Registry updated 2026-10-13

• NCT07005323

  Progression Suppression and Retinal Regression in VEGF-resistant AMD

  Trial Treatment · PharmaBio Corporation

  Hyogo Prefectural Amagasaki General Medical Center, Amagasaki · Nagoya City University Hospital, Nagoya · Yamaguchi University Hospital, Ube

  Registry updated 2026-09-18

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error